Hagens Berman probes Metropolitan Bank over credit quality claims

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Hagens Berman investigates Metropolitan Bank Holding Corp. for potential securities fraud regarding credit quality disclosures
  • Q2 2026 EPS of $1.54 missed consensus estimates of $2.28 due to unexpected credit loss provisions
  • Management previously described credit issues as a localized 'speed bump' involving only five credits
  • New $26 million C&I non-performing loan and $14 million in charge-offs contradicted earlier 'adequately reserved' claims
  • MCB shares dropped nearly 9% following the July 21 earnings release
powered bylight_fuzz_icon
51731999

*this image is generated using AI for illustrative purposes only.

Law firm Hagens Berman has launched an investigation into Metropolitan Bank Holding Corp. (NYSE: MCB) for potential securities law violations following a sharp stock drop and disappointing Q2 2026 financial results.

The inquiry centers on whether the bank and its executives issued materially false statements regarding credit quality and reserve adequacy during early 2026, prior to the July 21 earnings release.

Discrepancy in Credit Quality Narratives

During the Q1 earnings call and Annual General Meeting in April 2026, management characterized credit issues as a localized "speed bump" affecting only five specific credits. Executives assured investors that legacy loan concerns were fully contained and that the bank was "adequately reserved." They expressed confidence in a "full recovery" of principal, interest, and legal fees on troubled assets, including a specific Kansas City loan, and guided that criticized and classified loans would return to normal trends.

However, the Q2 results reported on July 21, 2026, revealed a starkly different reality. The bank posted an earnings per share (EPS) of $1.54, significantly missing consensus estimates of approximately $2.28. This miss was driven by a severe spike in credit loss provisions and unexpected write-downs across several isolated items, rather than the limited five-credit issue previously described.

Financial Impact and Charge-offs

The disclosure highlighted new non-performing loans and significant charge-offs that contradicted earlier assurances. A new $26 million commercial and industrial (C&I) non-performing loan emerged, alongside unexpected charge-offs totaling $14 million. These included $10 million related to C&I exposures and $4 million for a high-net-worth exposure. Additionally, a separate $10 million charge-off was recorded for a window and door manufacturer.

Furthermore, the final settlement for the Kansas City loan resulted in only a "partial reimbursement" of legal fees, contradicting the earlier guidance of full recovery. Following these disclosures, MCB shares fell nearly 9% in a single session as the market absorbed the deteriorating credit trends.

What the Numbers Show

The divergence between management's narrative and the actual financial outcomes highlights a concentration risk in the C&I portfolio that was not adequately reflected in prior reserve assumptions. The emergence of a single $26 million C&I NPL, combined with $10 million in C&I charge-offs, suggests that the "localized" nature of the credit issues claimed in April was inconsistent with the breadth of losses realized by July. The EPS shortfall of $0.74 against estimates underscores the materiality of these previously undisclosed or understated risks.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Will the Hagens Berman investigation trigger additional shareholder class-action lawsuits or regulatory inquiries from the SEC or OCC?

How might the significant C&I portfolio deterioration impact Metropolitan Bank Holding Corp.'s capital ratios and future dividend sustainability?

Are other regional banks with similar C&I concentration risks facing undisclosed credit quality issues that could lead to broader sector-wide de-rating?

like19
dislike

Hagens Berman probes MCB over Q2 earnings miss and credit risks

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Hagens Berman probes MCB for potential securities fraud after Q2 2026 results
  • Bank missed EPS estimates with $1.54 actual vs $2.28 consensus
  • $14 million in unexpected charge-offs contradicted earlier reserve assurances
  • Shares fell 8.96% to $90.19 following the earnings release
powered bylight_fuzz_icon
48873243

*this image is generated using AI for illustrative purposes only.

Securities law firm Hagens Berman Sobol Shapiro LLP has launched an investigation into potential securities fraud by Metropolitan Bank Holding Corp (NYSE: MCB) following disappointing Q2 2026 results.

The probe examines whether management misled investors regarding credit risks during early 2026, adding to scrutiny from Pomerantz LLP.

Investigation Focus

Hagens Berman alleges that Metropolitan and certain officers or directors may have engaged in unlawful business practices. The investigation centers on the July 21, 2026 earnings release, where the bank reported revenue and GAAP net income below analyst expectations.

Key concerns highlighted by Hagens Berman include:

  • Provisioning Spike: Credit loss provisions more than doubled to $13.3 million. Management attributed this surge to difficulties with a single commercial and industrial (C&I) loan and the charge-off of a commercial real estate loan.
  • Stock Decline: Following the results, shares fell $8.88 per share, or 8.96%, closing at $90.19 on July 22, 2026.

Hagens Berman Probe Details

Hagens Berman’s parallel investigation focuses on earlier disclosures from the Q1 earnings call and Annual General Meeting. Executives reportedly characterized credit issues as a contained "speed bump" involving only five specific credits and stated the bank was "adequately reserved."

The firm highlights a divergence between these assurances and Q2 realities:

  • Reserve Adequacy: Despite claims of adequate reserves, the bank recorded $14 million in unexpected new charge-offs, including $10 million for C&I loans, $4 million for a high-net-worth exposure, and a separate $10 million charge-off for a window and door manufacturer.
  • Portfolio Health: Earnings were impacted by isolated items, including a new $26 million C&I non-performing loan.
  • Loan Resolutions: A Kansas City loan settlement resulted in only partial reimbursement of legal fees, contradicting guidance for full recovery.
Disclosure Period Management Narrative Actual Outcome
Early 2026 / AGM Credit issues are a localized "speed bump"; fully contained Multiple isolated items; new $26M NPL
Reserve Status Bank is "adequately reserved" $14M in unexpected new charge-offs
Kansas City Loan Full recovery of principal and fees expected Partial reimbursement of legal fees only

Financial Impact

Metropolitan Bank reported Q2 2026 EPS of $1.54, missing consensus estimates of roughly $2.28. The miss was driven by severe spikes in credit loss provisions and unexpected write-downs.

What the Numbers Show

The divergence between the $1.54 actual EPS and the $2.28 consensus estimate underscores the severity of the unanticipated credit charges. The $14 million in unexpected charge-offs directly contradicted the "adequately reserved" narrative presented to investors months prior, suggesting that risk exposure was broader than disclosed.

Investor Action

Investors who purchased MCB securities and suffered losses are encouraged to contact either firm.

  • Pomerantz LLP: Contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
  • Hagens Berman: Contact Reed Kathrein at MCB@hbsslaw.com or 844-916-0895. Investors may also submit information via the firm’s website. Whistleblowers with non-public information may consider options under the SEC Whistleblower program.
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the dual investigations by Hagens Berman and Pomerantz LLP impact Metropolitan Bank Holding Corp's ability to raise capital or secure favorable lending terms in the near term?

Could the specific nature of the C&I and commercial real estate charge-offs signal a broader deterioration in Metropolitan's loan portfolio that extends beyond the 'isolated' incidents described by management?

What regulatory actions or increased scrutiny from the OCC or Federal Reserve might follow these allegations of misleading investors regarding credit risk reserves?

like17
dislike

More News on Metropolitan Bank Holding Corp